CalciMedica Revenue
Biotechnology Research • 
San Diego, California, United States • 11-20 Employees
CalciMedica revenue & valuation
| Annual revenue | $1,539,990 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $5,000,000 |
| Total funding | $10,000,000 |
Key Contacts at CalciMedica
Katherine Randolph
Sr. Director, Clinical Operations
Rachel Leheny
Chairman And Chief Executive Officer
Company overview
| Headquarters | 505 Coast Blvd S, Suite 307, La Jolla, California 92037, US |
| Phone number | +12126001902 |
| Websites | |
| SIC | 873 |
| Founded | 2007 |
| Employees | 11-20 |
| Socials |
CalciMedica Email Formats
CalciMedica uses 2 email formats. The most common is {first name} (e.g., john@calcimedica.com), used 58.3% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@calcimedica.com | 58.3% |
{first initial} | j@calcimedica.com | 41.7% |
About CalciMedica
CalciMedica is a clinical-stage biopharmaceutical company focused on developing novel CRAC channel inhibition therapies for inflammatory and immunologic diseases. CalciMedica's proprietary technology targets the inhibition of CRAC channels to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory and immunologic diseases for which there are currently no approved therapies. CalciMedica's lead product candidate Auxora™ has demonstrated positive and consistent clinical results in multiple completed efficacy clinical trials and been well-tolerated in over 350 critically ill patients dosed. CalciMedica has announced data for a Phase 2b trial (called CARPO – NCT04681066) in patients with acute pancreatitis (AP) and accompanying systemic inflammatory response syndrome (SIRS) and for a Phase 2 trial (called CARDEA – NCT04345614) in patients with COVID pneumonia. The Company is currently conducting a Phase 2 trial (called KOURAGE –NCT06374797) in patients with acute kidney injury (AKI) with associated acute hypoxemic respiratory failure (AHRF).
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
CalciMedica has 9 employees across 7 departments.
Departments
Number of employees
CalciMedica Tech Stack
Discover the technologies and tools that power CalciMedica's digital infrastructure, from frameworks to analytics platforms.
Form builders
Video players
Analytics
CDN
Font scripts
JavaScript libraries
Programming languages
Blogs
Analytics
UI frameworks
SEO
WordPress plugins
Australia
United Kingdom
Frequently asked questions
4.8
40,000 users
